1. Medicines and Healthcare products Regulatory Agency. Medicines Act 1968 advisory bodies: annual report 2010. London, MHRA, 2011. Online report available at https://doi.org/www.mhra.gov.uk/home/groups/l-cs-el/documents/websiteresources/con123351.pdf (accessed March 2013).
2. Information obtained from personal communication via B. Win of MHRA, November 2011.
3. Metters J . Report of an independent review of access to the yellow card scheme. London: The Stationery Office, 2004. Online report available at https://doi.org/www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con2015008.pdf (accessed March 2013).
4. Koch-Weser J, Sidel V W, Sweet R H, Kanarek P, Eaton A E . Factors determining physician reporting of adverse drug reactions – comparison of 2,000 spontaneous reports with surveillance studies at the Massachusetts General Hospital. N Eng J Med 1969; 280: 20–26.
5. Rogers A S, Israel E, Smith C R et al. Physician knowledge, attitudes and behaviour related to reporting adverse drug events. Arch Intern Med 1988; 148: 1596–1600.